Physician profile
Stuart D Helms
NPI 1780687186
$1,154.82
in general payments reported to CMS, 2019-2025
19 companies · $42.99 in 2025
The $42.99 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $916 · 2020: $176 · 2023: $19.03 · 2025: $42.99.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $62.02.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $62.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $191.08 | 2019 | |
| Novo Nordisk INC | $137.17 | 2019-2020 | |
| Astrazeneca Pharmaceuticals Lp | $104.50 | 2019-2020 | |
| Lilly USA, LLC | $89.86 | 2019-2020 | |
| Abbvie INC. | $81.80 | 2019-2023 | |
| Sanofi-Aventis U.S. LLC | $79.87 | 2019 | |
| Novartis Pharmaceuticals Corporation | $60.96 | 2019-2020 | |
| Teva Pharmaceuticals USA, INC. | $58.08 | 2019-2020 | |
| Allergan, INC. | $55.20 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $53.15 | 2019 | |
| Merck Sharp & Dohme LLC | $52.53 | 2019-2020 | |
| Amarin Pharma, INC. | $42.43 | 2019-2020 | |
| Arbor Pharmaceuticals, INC. | $28.72 | 2019 | |
| Pfizer INC. | $26.65 | 2019-2020 | |
| Astellas Pharma US INC | $23.95 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $22.39 | 2025 | Freestyle Libre 3 |
| Exact Sciences Corporation | $20.60 | 2025 | The Cologuard Plus Collection Kit |
| Janssen Pharmaceuticals, INC | $13.20 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $12.68 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stuart Helms listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.